Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

iRhythm Technologies Stock News

IRTCNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$144.81

At close: Jun 16 EDT

$146.25

1.440.99%

Pre-Market: 4:25 PM EDT

iRhythm Technologies (IRTC) Forecast

News

Earnings iRhythm Technologies (IRTC) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest iRhythm Technologies Stock News | NASDAQ:IRTC | Benzinga

Get the latest news on iRhythm Technologies stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on iRhythm Technologies performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, June 11, 2025

Expert Outlook: iRhythm Technologies Through The Eyes Of 6 Analysts
Benzinga Insights
Morgan Stanley Maintains Overweight on iRhyth...
Benzinga Newsdesk

Thursday, May 22, 2025

Demystifying iRhythm Technologies: Insights From 6 Analyst Reviews
Benzinga Insights
Citigroup Maintains Buy on iRhythm Technologi...
Benzinga Newsdesk

Sunday, May 04, 2025

Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Lekha Gupta

Friday, May 02, 2025

Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts
Vandana Singh
Canaccord Genuity Maintains Buy on iRhythm Te...
Benzinga Newsdesk
This FTAI Aviation Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday
Avi Kapoor
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Wells Fargo Upgrades iRhythm Technologies to ...
Benzinga Newsdesk
Baird Maintains Outperform on iRhythm Technol...
Benzinga Newsdesk
Deep Dive Into iRhythm Technologies Stock: Analyst Perspectives (5 Ratings)
Benzinga Insights
iRhythm Technologies shares traded higher aft...
Benzinga Newsdesk
Needham Maintains Buy on iRhythm Technologies...
Benzinga Newsdesk

Thursday, May 01, 2025

iRhythm Technologies Announces Commercial Lau...
Benzinga Newsdesk
iRhythm Technologies Raises FY2025 Sales Guid...
Benzinga Newsdesk
iRhythm Technologies Q1 Adj. EPS $(0.95) Beat...
Benzinga Newsdesk
Earnings Scheduled For May 1, 2025
Benzinga Insights

Monday, April 28, 2025

iRhythm Presents AVALON Study Results at HRS2...
Benzinga Newsdesk

Monday, February 24, 2025

Goldman Sachs Maintains Neutral on iRhythm Te...
Benzinga Newsdesk

Friday, February 21, 2025

Truist Securities Maintains Buy on iRhythm Te...
Benzinga Newsdesk
iRhythm Technologies shares are trading highe...
Benzinga Newsdesk
Wells Fargo Maintains Equal-Weight on iRhythm...
Benzinga Newsdesk
Breaking Down iRhythm Technologies: 6 Analysts Share Their Views
Benzinga Insights
Needham Maintains Buy on iRhythm Technologies...
Benzinga Newsdesk

Thursday, February 20, 2025

iRhythm Sees FY25 Revenue $675M-$685M Vs $679...
Benzinga Newsdesk
iRhythm Technologies Q4 Sales $164.30M Beat $...
Benzinga Newsdesk
Earnings Scheduled For February 20, 2025
Benzinga Insights

Monday, January 13, 2025

iRhythm Technologies shares are trading lower...
Benzinga Newsdesk
Needham Maintains Buy on iRhythm Technologies...
Benzinga Newsdesk
iRhythm Technologies Anticipates 2024 Revenue...
Benzinga Newsdesk

Wednesday, January 08, 2025

Oppenheimer Maintains Outperform on iRhythm T...
Benzinga Newsdesk

Wednesday, December 18, 2024

Truist Securities Maintains Buy on iRhythm Te...
Benzinga Newsdesk

Monday, December 09, 2024

Canaccord Genuity Maintains Buy on iRhythm Te...
Benzinga Newsdesk

Tuesday, December 03, 2024

Critical Insights From iRhythm Technologies Analyst Ratings: What You Need To Know
Benzinga Insights

Monday, December 02, 2024

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Vandana Singh

Friday, November 01, 2024

iRhythm Technologies shares are trading highe...
Benzinga Newsdesk
Baird Maintains Outperform on iRhythm Technol...
Benzinga Newsdesk

Thursday, October 31, 2024

Forecasting The Future: 6 Analyst Projections For iRhythm Technologies
Benzinga Insights
iRhythm Technologies shares are trading lower...
Benzinga Newsdesk
Needham Maintains Buy on iRhythm Technologies...
Benzinga Newsdesk

Wednesday, October 30, 2024

iRhythm Technologies Receives FDA 510(k) Clea...
Benzinga Newsdesk
iRhythm Sees FY24 Revenue $582.5M-$587.5M Vs ...
Benzinga Newsdesk
iRhythm Technologies Q3 2024 Adj EPS $(1.26) ...
Benzinga Newsdesk

Tuesday, October 29, 2024

Earnings Preview For iRhythm Technologies
Benzinga Insights

Monday, October 28, 2024

iRhythm Technologies Study Shows 14-Day Monit...
Benzinga Newsdesk

Sunday, October 27, 2024

Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?
Lekha Gupta

Tuesday, October 22, 2024

Nasdaq Turns Higher; Verizon Shares Fall After Q3 Results
Avi Kapoor
Truist Securities Maintains Buy on iRhythm Te...
Benzinga Newsdesk
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
Vandana Singh

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved